Search
for
Sort by
Research 31–60 of 243
- Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity
- Squamous epithelial proliferation induced by walleye dermal sarcoma retrovirus cyclin in transgenic mice
- Transcriptional and epigenetic mechanisms governing epidermal stem cell regulation
- Syndecan-1 Is Required to Maintain Intradermal Fat and Prevent Cold Stress
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Does fat get you skinny?
- LSD1 is Required for Hair Cell Regeneration in Zebrafish
- <i>N</i>1-acetylspermidine is a determinant of hair follicle stem cell fate
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors
- Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer
- Establishment and Characterization of Immortalized Human Dermal Papilla Cells Expressing Human Papillomavirus 16 E6/E7
- <i>BUZZ</i>: an essential gene for postinitiation root hair growth and a mediator of root architecture in <i>Brachypodium distachyon</i>
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- ATP-competitive mTOR kinase inhibitors delay plant growth by triggering early differentiation of meristematic cells but no developmental patterning change
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Development of Stratum Corneum Lipid Liposomes for Topical Drug Delivery
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth
- Topological Distribution of Wound Stiffness Modulates Wound-Induced Hair Follicle Neogenesis
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes